Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 19 for:    focus novo nordisk
Previous Study | Return to List | Next Study

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03811561
Recruitment Status : Recruiting
First Posted : January 22, 2019
Last Update Posted : April 9, 2021
Sponsor:
Information provided by (Responsible Party):
Novo Nordisk A/S

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 13, 2026
Estimated Study Completion Date : August 18, 2026